Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CGN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FTL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPS19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
U2AF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM234 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FUT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMAN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLUHP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FBXO7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA1522 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AFTPH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PEX16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC24C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPKAPK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on